Juxiang Chen

Tongji University — China

Medicine · Health Sciences

32h-index3.7kcitations130works8.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(48), Cancer, Hypoxia, and Metabolism(18), RNA modifications and cancer(15), MicroRNA in disease regulation(11), Ubiquitin and proteasome pathways(10)

Publications130 total

Activation of hypothalamic-pontine-spinal pathway promotes locomotor initiation and functional recovery after spinal cord injury in mice
Nature Communications·2025Open Access
A temporally functional composite hydrogel scaffold for cranial defect repair via sequential modulation of angiogenesis and osteogenesis
Theranostics·2025Open Access
Metabolomics of cerebrospinal fluid following traumatic brain injury: Exploration of biomarkers for secondary injuries and severity
Neurotherapeutics·2025Open Access
Synergistic Dual-Targeting Bacterial Extracellular Vesicles Delivering Paclitaxel for Precision Glioblastoma Therapy
Nano Letters·2025
Chemotherapeutic drug-triggered AEP-cleaved G3BP1 orchestrates stress granules/nucleoli/mitochondria in osteosarcoma
Bone Research·2025· 1 citedOpen Access
Activation of hypothalamic-pontine-spinal pathway promotes locomotor initiation and functional recovery after spinal cord injury in mice
2025Open Access
Targeting PGE2 mediated senescent neuron improves tumor therapy
Neuro-Oncology·2025· 5 citedOpen Access
SplitFusion enables ultrasensitive gene fusion detection and reveals fusion variant-associated tumor heterogeneity
Patterns·2025· 2 citedOpen Access
Brain-targeting drug delivery systems: The state of the art in treatment of glioblastoma
Materials Today Bio·2025· 25 citedOpen Access
Activation of hypothalamic-pontine-spinal pathway promotes locomotor initiation and functional recovery after spinal cord injury in mice
2024· 1 citedOpen Access
The Brain–Gut–Bone Axis in Neurodegenerative Diseases: Insights, Challenges, and Future Prospects
Advanced Science·2024· 23 citedOpen Access
AGBL4 promotes malignant progression of glioblastoma via modulation of MMP-1 and inflammatory pathways
Frontiers in Immunology·2024· 3 citedOpen Access
A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma
Redox Biology·2024· 25 citedOpen Access
Dysregulated inter-mitochondrial crosstalk in glioblastoma cells revealed by in situ cryo-electron tomography
Proceedings of the National Academy of Sciences·2024· 7 citedOpen Access
UBDP1 pseudogene and UBD network competitively bind miR‑6072 to promote glioma progression
International Journal of Oncology·2024· 3 citedOpen Access
Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma
Nature Communications·2024· 53 citedOpen Access
Exploring cerebral structural and functional abnormalities in a mouse model of post-traumatic headache induced by mild traumatic brain injury
动物学研究·2024· 3 citedOpen Access
Step-by-step dissection of the pterygopalatine fossa, infratemporal fossa, and parapharyngeal space via the middle cranial fossa approach with preservation of the temporomandibular joint
Turkish Neurosurgery·2024Open Access
FOXO1-miR-506 axis promotes chemosensitivity to temozolomide and suppresses invasiveness in glioblastoma through a feedback loop of FOXO1/miR-506/ETS1/FOXO1
Journal of Zhejiang University SCIENCE B·2023· 4 citedOpen Access
Data from Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in <i>IDH</i>-Mutant Gliomas
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Yicheng Lu(18), Hongxiang Wang(16), Yong Yan(15), Tao Xu(13), Guohan Hu(13), Qilin Huang(12), Chun Luo(9), Jinxu Zhou(6), Chao Chen(5), Hanchong Xu(4), Da Fu(4), Lijun Hou(4), Hongxiang Wang(4), Weiqing Li(4), Kang Ying(4), Zhenyu Gong(4), Yufeng Shi(3), Huairui Chen(3), Junyu Wang(3), Xiaoping Zhang(3)